Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. ProtoKinetix, Inc. (PKTX) Message Board

***PKTX...Dear Protokinetix Investors...Over the y

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 88
(Total Views: 326)
Posted On: 08/26/2018 9:33:14 AM
Posted By: Onedown
***PKTX...Dear Protokinetix Investors...Over the years as an investor with Protokinetix, I have had the opportunity to witness many of PKTX's medical research projects using it's molecule..AAGP.. I try to do my own research to understand more about about these projects..

...PKTX latest PR News Release(August 10, 2018)"ProtoKinetix Enters into 3rd Phase of Retinal Cell Replacement Therapy Testing at UBC" .. Was an eye opener after starting to dig for more information on this on-going research with Macular Degeneration..

...One part of my search I found something that was very, very interesting..... Macular Degeneration is the leading cause of vision loss, affecting more than 10 million Americans – more than cataracts and glaucoma combined. At present, Macular Degeneration is considered an incurable eye disease.

....That part of the statement is Very Hard Hitting..."AT PRESENT, Macular Degeneration is considered an incurable eye disease".

...With Dr. Gregory-Evans and his research team working at the Gregory-Evans Retinal Therapeutics Lab(University of British Columbia)...Presently working on the Third(3rd)Phase to identify new ways of treating common retinal diseases, such as macular degeneration and retinitis pigmentosa. This work will focus on novel cell-based therapeutic strategies in model systems (e.g. rodents models of eye disease) and clinical trials. We are undertaking a number of projects to look at how cells can be used to replace damaged retinal tissue and also new ways that cells can be used to deliver and secrete drugs long-term into the diseased retina to prevent further decline of vision.

****Folks...Does this Not tell you something......That Protokinetix's molecule...AAGP....... Works..!

...People...(IMHO)...I've said it once and I'll say it again....Protokinetix will Be the Next Microsoft of the Biotech World(Everybody will Want It and Need it)..!
...WHY...? Because the molecule Kicks Butt and Works..! :+O


(0)
(0)




ProtoKinetix, Inc. (PKTX) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us